echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Crit Care: Clinical features and risk factors of death in patients with severe community-acquired pneumonia and type 2 diabetes

    Crit Care: Clinical features and risk factors of death in patients with severe community-acquired pneumonia and type 2 diabetes

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Community-acquired pneumonia (CAP) is the leading cause of adult infections worldwide and is associated with high hospitalization rates and length of stay (LOS)
    .

    Infect

    Recently, a research article was published in Critical Care, an authoritative journal in the field of critical care medicine, which aims to investigate the impact of type 2 diabetes (T2DM) on severe community-acquired pneumonia (SCAP) and develop a new type of SCAP for T2DM patients The prediction model of mortality
    .

    diabetes

    This is a retrospective observational study in which researchers analyzed adult SCAP patients who were admitted to the Intensive Care Unit (ICU) of West China Hospital of Sichuan University from September 2011 to September 2019
    .


    The main outcome of the study was the hospital mortality of the subjects


    After PSM, the study included a total of 1262 SCAP patients with T2DM and 2524 matched patients without T2DM
    .


    Patients with T2DM have longer ICU hospital stays (LOS) (13 days vs.


    Compared with non-diabetic patients, SCAP patients with T2DM have worse clinical outcomes
    .


    The nomogram has a good predictive performance for hospital mortality


    Compared with non-diabetic patients, SCAP patients with T2DM have worse clinical outcomes


    Original source:

    Dong Huang,et al.


    Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia and type 2 diabetes mellitus in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.